secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001104659-24-128901
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics cuts workforce by 23% (5 employees) to preserve capital
----------------------------------------------------------------------------

- Board approved reduction of 5 employees (~23% of headcount) on Dec 10; effective Dec 13.
- Estimated restructuring charges of ~$0.3 million for severance, benefits, and related costs.
- Majority of cash payments expected to be substantially complete by end of Q3 2025.
- Severance contingent on release of claims; includes COBRA premiums for specified period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/0001104659-24-128901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465924128901/tm2431046d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-128901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer